Fulgent Genetics
FLGT
20.57
-0.01
-0.05%
Fulgent Genetics
US · FLGT
#3667 by market cap
Listed 2016
20.57
-0.01
-0.05%
Live - 5344 symbols - heartbeat 307s ago
· 2026-10-07 19:54
After-hours
20.57
0.00%
- Market cap
- 565.99M
- P/E (TTM)i
- -7.27
- P/Bi
- 0.57
- EPSi
- -1.97
- Div yieldi
- 0.00%
- 52W posi
- 40%
Reader sentiment
Are you bullish or bearish on FLGT?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Raises Target Price to $23Market Newswire · 2025/5/7
-
Rating change
Raymond James Maintains Fulgent Genetics(FLGT.US) With Buy Rating, Announces Target Price $25Market Newswire · 2025/5/6
-
Rating change
Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $16Market Newswire · 2025/3/4
-
Rating change
Raymond James Maintains Fulgent Genetics(FLGT.US) With Buy Rating, Maintains Target Price $25Market Newswire · 2025/8/4
-
Rating change
UBS Maintains Fulgent Genetics(FLGT.US) With Buy Rating, Raises Target Price to $35Market Newswire · 2025/11/10
-
Rating change
Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $22Market Newswire · 2024/11/11
-
Rating change
Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $21Market Newswire · 2025/8/4
-
Fulgent Genetics (FLGT.US) will release its earnings report before the market opens on May 1.Market Newswire · 2026/4/28
-
Rating change
Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Raises Target Price to $30Market Newswire · 2025/11/11
-
Rating change
UBS Initiates Fulgent Genetics(FLGT.US) With Buy Rating, Announces Target Price $30Market Newswire · 2025/8/5
-
Earnings Call Summary | Fulgent Genetics(FLGT.US) Q1 2026 Earnings ConferenceMarket Newswire · 2026/5/2
-
Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $19Market Newswire · 2026/8/4
-
UBS Maintains Fulgent Genetics(FLGT.US) With Buy Rating, Cuts Target Price to $22Market Newswire · 2026/3/2
-
Rating change
UBS Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $20Market Newswire · 2025/3/3
-
Fulgent Genetics (FLGT.US) will release its earnings report after market close on July 30.Market Newswire · 2026/7/25
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.